Aligos Therapeutics (ALGS)
(Delayed Data from NSDQ)
$7.91 USD
-0.09 (-1.13%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $7.94 +0.03 (0.38%) 5:52 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ALGS 7.91 -0.09(-1.13%)
Will ALGS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALGS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALGS
Aligos Therapeutics, Inc. (ALGS) Reports Q1 Loss, Misses Revenue Estimates
Aligos Therapeutics, Inc. (ALGS) Reports Q4 Loss, Lags Revenue Estimates
ALGS: What are Zacks experts saying now?
Zacks Private Portfolio Services
UniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates
Keros Therapeutics, Inc. (KROS) Reports Q4 Loss, Misses Revenue Estimates
PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last?
Other News for ALGS
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025 | ALGS ...
Aligos Therapeutics (ALGS) Grants Stock Options to New Employees | ALGS Stock News
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ALGS ...
Aligos Therapeutics announces inducement grants under Nasdaq listing rule
Aligos Therapeutics Approves Major Amendments at Annual Meeting